Page 110 - Aet News Today

A Phase 2b-ready Cyclerion Therapeutics drug candidate for a rare mitochondrial disease gets new life under a new startup led by a familiar face. Starup Tisento Therapeutics acquired the Cyclerion drug and is backed by a Series A round financing.

TG Therapeutics’ multiple sclerosis drug Briumvi will be commercialized in Europe by Neuraxpharm. The Germany-based company paid $140 million up front for certain rights to the drug, which received European Commission approval in June.

We need a streamlined approach where stakeholders can perform all critical tasks — from enrollment and patient consent to prior authorization, from real-time benefit checks to financial assistance — on a central platform powered by a business rules engine, automated workflows, and real-time analytics.

HerMD recently raised $18 million in a Series A-1 funding round. The company offers in-person and virtual women's healthcare that focuses on menopause and sexual health. It is using its new capital to open more brick-and-mortar women's health centers across the country.

AI can index company narratives relative to strategy, opportunities, and threats, and create benchmarks to watch over time related to sentiment, intensity, and impressions. Ultimately these can be tied back to ROI and stakeholder value that move past typical marketing performance metrics or traditional brand metrics.

Hello Alpha launched Ahead with Alpha, a weight management program for employers. It offers access to primary care providers trained in obesity care, medication management through weight loss drugs like GLP-1s, nutrition counseling with a registered dietitian and progress tracking. 

As clinical psychologists, we talk about therapy as the gold standard. I’m not saying it isn’t, but if only a minority of people are getting it, we need to broaden our perspective.

OptumRx's Chief Clinical Officer shares his insights on the latest developments and trends he's seen in the healthcare industry.

Biopharma companies are harnessing AI tools for multiple aspects of drug development such as identifying drug development targets, modeling a drug's effect on the body, and more.

Kindbody is now on Quantum Health’s Comprehensive Care Solutions platform, which offers a selection of benefits solutions that the company’s more than 500 employer clients can choose to contract with.